Successful Administration of Recombinant Human Soluble Thrombomodulin <i>α</i> (Recomodulin) for Disseminated Intravascular Coagulation  during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) <i>MLL/AF9</i> Translocation

<table>Karyotype analysis showed t(9;11)(p22;q23). At the time of diagnosis, bone marrow cells were analyzed by commercially available service (BML laboratory, Japan). Twenty of the 20 metaphases cells disclosed t(9;11)(p22;q23) in G-banding method.</table>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Successful Administration of Recombinant Human Soluble Thrombomodulin <i>α</i> (Recomodulin) for Disseminated Intravascular Coagulation  during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) <i>MLL/AF9</i> Translocation 

Figure 1 | Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation  during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation 